$SRFM Balance Sheet | Understand Stock

$SRFM

$0.71 -$0.06 (8.16%) Close

$SRFM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Unaudited Condensed Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023
Assets
Current assets:
Cash
Accounts receivable, net
Prepaid expenses and other current assets
Total current assets
Restricted cash
Property and equipment, net
Intangible assets, net
Operating lease right-of-use assets
Finance lease right-of-use assets
Goodwill
Other assets
Total assets
Liabilities and Shareholders' Deficit:
Current liabilities:
Accounts payable
Accrued expenses
Accrued expenses and other current liabilities
Deferred revenue
Current maturities of long-term debt
Operating lease liabilities, current
Finance lease liabilities, current
SAFE notes at fair value, current
Convertible notes at fair value, current
Due to related parties, current
Related Party
Total due to related parties, current
Total current liabilities
Long-term liabilities:
Long-term debt, net of current maturities
Convertible notes at fair value, long term
Operating lease liabilities, long term
Finance lease liabilities, long term
SAFE notes at fair value, long term
Due to related parties, long term
Other long-term liabilities
Total liabilities

Redeemable convertible preferred shares $0.001 par value; 0 and 263,459,277 shares authorized as of December 31, 2023 and December 31, 2022, respectively; 0 shares issued and outstanding as of December 31, 2023 and 229,144,283 shares issued and outstanding as of December 31, 2022; and aggregate liquidation preference of $0 as of December 31, 2023 and $178,608 as of December 31, 2022
Common Stock, $0.0001 par value; 3,510,638 and 0 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively (Note 12).
Shareholders' deficit:
Preferred Stock, $0.0001 par value; 50,000,000 shares authorized; 0 shares issued and outstanding at June 30, 2026 and December 31, 2025
Common stock, $0.0001 par value; 800,000,000 shares authorized as of both June 30, 2026 and December 31, 2025; 119,137,993 shares issued and outstanding as of June 30, 2026 and 73,082,025 shares issued and outstanding as of December 31, 2025
Additional paid-in capital
Accumulated deficit
Total shareholders' deficit
Total liabilities and shareholders' deficit

Comments